4.7 Article

Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer's disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Clinical Neurology

Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Fangda Leng et al.

Summary: Microglial activation and neuroinflammation play important roles in Alzheimer's disease, affecting disease progression and pathologies. Current research focuses on the interplay between neuroinflammation and amyloid and tau pathologies, with a specific interest in modulating microglia as a therapeutic strategy for AD.

NATURE REVIEWS NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome

Mathieu Bourdenx et al.

Summary: This study reveals that loss of neuronal CMA leads to altered neuronal function, changes in the neuronal proteome, and proteotoxicity, while enhancing CMA can ameliorate pathology in Alzheimer's disease mouse models. Functional CMA is essential for maintaining neuronal proteostasis and protecting against neurodegenerative diseases.
Article Multidisciplinary Sciences

Gasdermin D pore structure reveals preferential release of mature interleukin-1

Shiyu Xia et al.

Summary: Inflammasomes activate caspase-1 to cleave GSDMD and generate mature cytokines like IL-1 beta and IL-18, which are released through pores formed by GSDMD. The GSDMD pore mediates IL-1 release by electrostatic filtering, favoring the passage of mature cytokines over their precursors.

NATURE (2021)

Article Pharmacology & Pharmacy

Aducanumab: First Approval

Sohita Dhillon

Summary: Aducanumab is a monoclonal antibody developed for the treatment of Alzheimer's disease, targeting aggregated forms of amyloid beta. It has received approval in the USA for use in patients with mild cognitive impairment or mild dementia. Ongoing studies are evaluating its safety and efficacy in patients with early Alzheimer's disease.
Review Cell Biology

Autophagy in healthy aging and disease

Yahyah Aman et al.

Summary: This Review discusses the recent research on the mechanisms and roles of autophagy in health, aging, and disease, and how drugs modulating autophagy process could be used to suppress age-associated diseases. It examines emerging features of autophagy and proposes the potential links to aging and disease progression. The review also highlights the importance of understanding the interplay between autophagy and age-related pathologies for the development of clinical applications promoting long-term health.

NATURE AGING (2021)

Article Clinical Neurology

Baicalein Attenuates Neuroinflammation by Inhibiting NLRP3/Caspase-1/GSDMD Pathway in MPTP-Induced Mice Model of Parkinson's Disease

Wenjuan Rui et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2020)

Article Neurosciences

Beta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia

Yang Liu et al.

NEUROSCIENCE LETTERS (2020)

Review Clinical Neurology

Systemic and CNS Inflammation Crosstalk: Implications for Alzheimer's Disease

Evi Paouri et al.

CURRENT ALZHEIMER RESEARCH (2019)

Review Neurosciences

Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions

David R. Elmaleh et al.

JOURNAL OF ALZHEIMERS DISEASE (2019)

Article Multidisciplinary Sciences

NLRP3 inflammasome activation drives tau pathology

Christina Ising et al.

NATURE (2019)

Review Clinical Neurology

Inflammation in ALS/FTD pathogenesis

Madelyn E. McCauley et al.

ACTA NEUROPATHOLOGICA (2019)

Article Clinical Neurology

Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias

Eleanor King et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

Article Multidisciplinary Sciences

Innate immune memory in the brain shapes neurological disease hallmarks

Ann-Christin Wendeln et al.

NATURE (2018)

Review Neurosciences

Inflammasome signalling in brain function and neurodegenerative disease

Michael T. Heneka et al.

NATURE REVIEWS NEUROSCIENCE (2018)

Article Clinical Neurology

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease

Alice J. White et al.

FRONTIERS IN NEUROLOGY (2018)

Article Multidisciplinary Sciences

Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease

Carmen Venegas et al.

NATURE (2017)

Review Neurosciences

The blood-brain barrier in Alzheimer's disease

Elena Zenaro et al.

NEUROBIOLOGY OF DISEASE (2017)

Article Clinical Neurology

Inflammasomes as therapeutic targets for Alzheimer's disease

Claire S. White et al.

BRAIN PATHOLOGY (2017)

Article Neurosciences

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease

Marina Saresella et al.

MOLECULAR NEURODEGENERATION (2016)

Review Immunology

Inflammasomes: mechanism of assembly, regulation and signalling

Petr Broz et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Review Immunology

Regulation of inflammasome activation

Si Ming Man et al.

IMMUNOLOGICAL REVIEWS (2015)

Article Multidisciplinary Sciences

Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death

Jianjin Shi et al.

NATURE (2015)

Article Multidisciplinary Sciences

NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice

Michael T. Heneka et al.

NATURE (2013)

Review Clinical Neurology

Review: Systemic inflammation and Alzheimer's disease

C. Holmes

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)

Review Clinical Neurology

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

Etienne C. Hirsch et al.

LANCET NEUROLOGY (2009)

Review Geriatrics & Gerontology

Inflammation and Alzheimer's disease

H Akiyama et al.

NEUROBIOLOGY OF AGING (2000)